Stock Events

Ultragenyx Pharmaceutical (RARE.MX) Q2 2017 Earnings

4MayConfirmed
Q2 2016
Q4 2016
Q1 2017
Q2 2017
-35.71
-31.73
-27.75
-23.77

Details

Expected EPS
-32.291506
Actual EPS
-31.145061999999996
Surprise EPS
1.15
Surprise Percent
+3.55%

Description

Ultragenyx Pharmaceutical (RARE.MX) has reported earnings of -31.145061999999996 per share for Q2 2017.

0 Comments

Share your thoughts